EGFR and glioblastoma: PROTACs are prime examples and they are already being adapted to oncoproteins also relevant for GBM including BRD4 (Myc) (Figure 6), ERK1,2 (MAP kinase pathway), EGFR and CDK4/6 (404, 420–423).